Alzheimer's 'wonder' drugs can delay move to care home by nearly a year, new study suggests - but experts warn of side effects
A new family of Alzheimer's drugs said to be 'revolutionary' by some doctors could give patients roughly an extra year of independent life, a study suggests. Experts analysed previous data from clinical trials and found those in mild stages of the disease who use the medicines lecanemab and donanemab could remain living independently for an extra 10 months. Previous estimates suggested the drugs could slow the progression of the disease by only between four and seven months.
Read More >> Full Article on Source: MAG NEWS
#US #ShowBiz #Sports #Politics #Celebs #Zelensky #Tulsi #Moscow #Massachusetts #Whoopi #Schumer
